Back to blog
Environmental Monitoring7 min readMarch 18, 2026

Updated · Sources and guidance reviewed for this revision.

5 Environmental Monitoring Gaps to Review Before an FDA Inspection

Separate the monitoring program from the sensor system

A cleanroom temperature chart cannot demonstrate microbial control by itself. A useful review distinguishes viable air and surface sampling, nonviable particle certification, personnel sampling, and physical conditions such as temperature, humidity and pressure. FDA’s environmental monitoring presentation addresses expectations for both 503A pharmacies and 503B outsourcing facilities.

The five gaps below are review prompts, not a ranking of inspection findings or a prediction that a facility will receive a Form 483. Apply the official USP chapter, your jurisdiction’s requirements, and the federal framework for your operation.

1. A sampling plan that does not match actual work

Compare the location map with current rooms, equipment, workflows and sampling records. A renamed hood or replacement sensor can break continuity if results appear under a different location. Preserve stable equipment and location identities, the collection method and the relevant operating conditions.

Evidence to retrieve: the approved plan, current map, sampling schedule, missed-sample decisions, and results at each named location. Continuous sensors can support physical-condition monitoring, but do not replace viable sampling or certification. Avoid assuming every ISO 5 device requires a dedicated humidity sensor or that manual readings are universally prohibited.

2. Excursions without a documented impact assessment

An alert acknowledgment records receipt, not resolution. Link the source result to an investigation, affected time window, possible preparation impact, immediate containment, and the responsible reviewer’s disposition. A later normal reading does not explain the earlier event.

FDA’s insanitary-conditions guidance explains why environmental and procedural failures can threaten sterile preparations. Use your approved procedure to determine the response; do not automatically close an event merely because a sensor returns to range.

3. Trend reviews with no comparable context

Review results by location, sample type and collection conditions. Check repeated low-level recoveries, organism patterns, missed collections, and changes in cleaning or occupancy. A facility-wide average may hide a recurring problem at one work surface.

Statistical process control may support analysis when the data and method are suitable. It is not a universal USP requirement to put every parameter on an SPC chart or adopt an arbitrary monthly cadence. Define review intervals, methods and escalation criteria in the program and retain the reviewer’s conclusion.

4. Returning a changed area to service without review

After maintenance or a facility change, document what changed, how it could affect environmental control, and what certification, qualification or sampling evidence is needed before use. The appropriate evidence depends on the change and applicable requirements. A generic five-day protocol is not a universal release criterion.

Link the work order and acceptance evidence to the room or equipment record. Keep open deficiencies visible to the person authorized to release the area.

5. Missing calibration and outage context

Retrieve the monitoring device identity, calibration or verification record, acceptance criteria and next due date. If a device is found outside tolerance, assess the reliability of earlier measurements and the affected decisions. During an outage, preserve both observation time and entry time for backup readings.

CompliRx’s backup-reading workflow explains why manual observations must retain their source identity. An automated alert remains dependent on configured thresholds, connectivity and a staffed response procedure.

From a finding to a reviewable record

Trace one event through investigation and CAPA effectiveness review, then retrieve the evidence using the USP <797> self-assessment. The environmental monitoring software page shows how CompliRx organizes related records. Software supports this work; purchasing it does not establish compliance.

Does continuous monitoring replace viable sampling?

No. Physical-condition measurements and microbiological sampling answer different questions. Keep both programs and their evidence distinct.

CE

CompliRx Editorial

Compliance & Regulatory Team

Prepared by CompliRx. Regulatory sources and product workflow references are identified in the article where available; no independent professional review is implied.

Share this article

More articles

Related articles

See CompliRx on a facility like yours.

See how CompliRx helps compounding pharmacies stay inspection-ready with automated monitoring, documentation, and training management.